Author:
Klotz Daniel Martin,Penfold Rose Sarah
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Zanusso G, et al. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease. Nat Rev Neurol. 2016;12(6):325–33.
2. National CJD Research & Surveillance Unit. The University of Edinburgh. 2017.
http://www.cjd.ed.ac.uk
. Accessed 20 May 2017.
3. Public Health England. Public health action following a report of a new case of CJD or a person at increased risk of CJD. Public Health England. 2015.
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/474338/CJD_public_health_action_new_case_301015.pdf
. Accessed 24 May 2017.
4. Rabinovici GD, Wang PN, Levin J, Cook L, Pravdin M, Davis J, DeArmond SJ, Barbaro NM, Martindale J, Miller BL, Geschwind MD. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006;66(2):286–7.
5. Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003;60(6):813–6.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献